Improve hand dexterity with phygital
- Trial ID
- NCT07475741
- Official Title
- Exergaming With Physical Onjects for Upper Limb Rehabilitation in Parkinson's Disease: Effects on Functional Outcome
- Goal
- Improve hand dexterity with phygital
- Phase
- NA
- Status
- RECRUITING
- Sponsor
- University of Health Sciences Lahore
- Study Type
- INTERVENTIONAL
- Enrollment
- 30 participants
- Conditions
- Parkinsons Disease (PD)
- Interventions
- Exergaming, Conventional Physical Therapy
Summary For Families
The goal is to improve upper limb function and everyday hand use in people with early-stage Parkinson's, by comparing an engaging exergaming approach to conventional physical therapy. The exergaming uses interactive games that require manipulating physical objects to train strength, coordination, fine motor control and timing, a form of repetitive, task-specific practice that supports motor learning and neuroplasticity, and it is a rehabilitative approach that complements levodopa/carbidopa rather than replacing or chemically interacting with it. The trial is looking for adults 45 to 85 with Hoehn and Yahr stage I to III PD who can follow commands, have an MMSE of 24 or higher, and are on regular levodopa/carbidopa, while excluding advanced-stage disease, significant cognitive impairment, other neurologic or musculoskeletal hand problems, or use of medicines for systemic illnesses.
Locations
- Punjab institute of Neuroscience Lahore, Lahore, Punjab Province, Pakistan
Frequently Asked Questions
- What is this trial testing?
- This trial is studying Exergaming. The goal is to improve upper limb function and everyday hand use in people with early-stage Parkinson's, by comparing an engaging exergaming approach to conventional physical therapy. The exergaming uses interactive games that require manipulating physical objects to train strength, coordination, fine motor control and timing, a form of repetitive, task-specific practice that supports motor learning and neuroplasticity, and it is a rehabilitative approach that complements levodopa/carbidopa rather than replacing or chemically interacting with it. The trial is looking for adults 45 to 85 with Hoehn and Yahr stage I to III PD who can follow commands, have an MMSE of 24 or higher, and are on regular levodopa/carbidopa, while excluding advanced-stage disease, significant cognitive impairment, other neurologic or musculoskeletal hand problems, or use of medicines for systemic illnesses.
- Who can participate?
- Participants must be between 45 Years and 85 Years.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- No. There is no cost to participate. Study-related care and treatment are provided at no charge.
- How long does the trial last?
- This trial is estimated to last approximately 6 months.
- Will I get the real drug or a placebo?
- It depends on the trial design. Some Parkinson's trials are placebo controlled, meaning a portion of participants get an inactive comparison while others get the experimental treatment. Some use crossover designs so everyone eventually receives the active treatment at some point. Observational trials do not use a placebo at all because they are not testing a new treatment. The consent form for any specific trial spells out the design and your odds of being assigned to placebo before you enroll.
- How often will I need to visit the study site?
- Visit frequency varies by trial. Many Parkinson's studies require an in person visit every 4 to 12 weeks during the active treatment phase, with shorter or longer gaps depending on the design. The site coordinator can give you the full visit schedule before you sign anything, so you know what the time commitment looks like.
- Can I leave the trial if I change my mind?
- Yes. You can withdraw from any clinical trial at any time, for any reason, without affecting your standard medical care. Trials are voluntary by law. The team may ask if you are willing to do a brief exit visit so they can collect safety information, but you are not obligated.
- Will travel or parking be reimbursed?
- Many trials reimburse for parking, mileage, and sometimes lodging if the site is far from your home. Reimbursement policies vary by sponsor and site. When you contact the trial team, ask specifically what is covered and how reimbursement is processed.
- Can my spouse or care partner come with me to visits?
- In most cases yes, and it is often encouraged. Care partners can help with notes, questions, and getting home safely after a long visit. Some study assessments do need to happen one on one, but care partners are usually welcome for the rest of the appointment.